Usage of Orange Peel Extract in Management of Epistaxis
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Orange.
- Who it may be relevant to
- Registry conditions: Epistaxis. Basic parameters: 5 years — 15 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
The Potential of Nano-based Gel of Orange Peel Extract in Management of Epistaxis : a Randomized Double Blind Clinical Study
Overview
Efficacy of orange peel extract in treatment of epistaxis in children
Detailed description
Formulation of orange peel extract into gel substance and usage of it in local treatment of epistaxis
Interventions
- Dietary supplement Orange
usage of orange peel extract in gel layer in treatment of epistaxis
Primary outcome measures
- The potential of nano-based gel of Orange peel extract in management of epistaxis [Time frame: From enrollment to the end of treatment at 4 weeks]
Eligibility criteria
Inclusion criteria
- children with anterior epistaxis from little's area
Exclusion criteria
- patient with nasal polyp.
- patients with hematological abnormalities.
- patients with general diseases affecting coagulation system.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Center list to be confirmed — check the primary protocol.
Publications
- Andrade MA, Barbosa CH, Shah MA, Ahmad N, Vilarinho F, Khwaldia K, Silva AS, Ramos F. Citrus By-Products: Valuable Source of Bioactive Compounds for Food Applications. Antioxidants (Basel). 2022 Dec 25;12(1):38. doi: 10.3390/antiox12010038. PMID 36670900
Identifiers
NCT: NCT06836102 · orange peel in epistaxis